These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35818327)

  • 1. Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway.
    Fan Z; Dong J; Mu Y; Liu X
    Bioengineered; 2022 Jun; 13(6):14670-14681. PubMed ID: 35818327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
    Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy.
    Zuo G; Ren X; Qian X; Ye P; Luo J; Gao X; Zhang J; Chen S
    J Cell Physiol; 2019 Feb; 234(2):1925-1936. PubMed ID: 30067872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptozotocin-induced diabetic cardiomyopathy in rats: ameliorative effect of PIPERINE via Bcl2, Bax/Bcl2, and caspase-3 pathways.
    Wang Y; Sun H; Zhang J; Xia Z; Chen W
    Biosci Biotechnol Biochem; 2020 Dec; 84(12):2533-2544. PubMed ID: 32892714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effects of S14G-humanin (HNG) against streptozotocin (STZ)-induced cardiac dysfunction.
    Chen X; Yun C; Zheng H; Chen X; Han Q; Pan H; Wang Y; Zhong J
    Bioengineered; 2021 Dec; 12(1):5491-5503. PubMed ID: 34506248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of acorn (Quercus liaotungensis Koidz) on streptozotocin-damaged MIN6 cells and type 2 diabetic rats via p38 MAPK/Nrf2/HO-1 pathway.
    Xu J; Fu C; Li T; Xia X; Zhang H; Wang X; Zhao Y
    J Ethnopharmacol; 2021 Feb; 266():113444. PubMed ID: 33027641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals.
    Wang Y; Cai F; Li G; Tao Y
    Bioengineered; 2022 Apr; 13(4):9184-9196. PubMed ID: 35383532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative potentials of the ethanolic extract from Lycium chinense leaf extract against diabetic cardiomyopathy. Insight into oxido-inflammatory and apoptosis modulation.
    Wen C; Liu C; Li Y; Xia T; Zhang X; Xue S; Olatunji OJ
    Biomed Pharmacother; 2022 Oct; 154():113583. PubMed ID: 35994819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats.
    Raish M; Ahmad A; Bin Jardan YA; Shahid M; Alkharfy KM; Ahad A; Ansari MA; Abdelrahman IA; Al-Jenoobi FI
    Biomed Pharmacother; 2022 Jan; 145():112412. PubMed ID: 34768051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats.
    Othman AI; El-Sawi MR; El-Missiry MA; Abukhalil MH
    Biomed Pharmacother; 2017 Oct; 94():362-373. PubMed ID: 28772214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate ameliorates testicular damage in rats with streptozotocin-induced type 1 diabetes: role of HO-1 and p38 MAPK.
    Abdel-Aziz AM; Abozaid SMM; Yousef RKM; Mohammed MM; Khalaf HM
    Pharmacol Rep; 2020 Dec; 72(6):1645-1656. PubMed ID: 32515004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hinokinin alleviates high fat diet/streptozotocin-induced cardiac injury in mice through modulation in oxidative stress, inflammation and apoptosis.
    Lu Q; Zheng R; Zhu P; Bian J; Liu Z; Du J
    Biomed Pharmacother; 2021 May; 137():111361. PubMed ID: 33761596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
    Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of betaine on diabetic induced disruption of the male mice blood-testis barrier by regulating oxidative stress-mediated p38 MAPK pathways.
    Jiang YP; Yang JM; Ye RJ; Liu N; Zhang WJ; Ma L; Zheng P; Niu JG; Liu P; Yu JQ
    Biomed Pharmacother; 2019 Dec; 120():109474. PubMed ID: 31585299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesfatin-1 alleviates high glucose/high lipid-induced injury of trophoblast cells during gestational diabetes mellitus.
    He H; Liu Y; Sun M
    Bioengineered; 2021 Dec; 12(2):12789-12799. PubMed ID: 34895049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
    Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
    Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ellagic acid protects against diabetic cardiomyopathy in rats by stimulating cardiac silent information regulator 1 signaling.
    Altamimi JZ; Alfaris NA; Alshammari GM; Alagal RI; Aljabryn DH; Aldera H; Alkhateeb MA; Yahya MA
    J Physiol Pharmacol; 2020 Dec; 71(6):. PubMed ID: 33901999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Protective Effect of 11-Keto-β-Boswellic Acid against Diabetic Cardiomyopathy in Rats Entails Activation of AMPK.
    AlTamimi JZ; AlFaris NA; Alshammari GM; Alagal RI; Aljabryn DH; Yahya MA
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaempferol protects against streptozotocin-induced diabetic cardiomyopathy in rats by a hypoglycemic effect and upregulating SIRT1.
    Alshehri AS; El-Kott AF; Eleawa SM; El-Gerbed MSA; Khalifa HS; El-Kenawy AE; Albadrani GM; Abdel-Daim MM
    J Physiol Pharmacol; 2021 Jun; 72(3):. PubMed ID: 34810287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.